Alterity Therapeutics (ATHE) EV to EBIT (2009 - 2025)

Alterity Therapeutics (ATHE) EV to EBIT (2009 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBIT
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 232,854.65
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -41,251.84
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 604.41
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 25.48
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn 10,112.54
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 15.49
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 43.12
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 49.30
9 Revolution Medicines 37.15 Bn 37.15 Bn - -84.03
10 Alterity Therapeutics - - - 0.00

Historic Data

Download Data
DateValue
Dec 30, 2025 -2,517.34
Dec 29, 2025 -2,484.43
Dec 26, 2025 -2,607.83
Dec 24, 2025 -2,550.24
Dec 23, 2025 -2,542.02
Dec 22, 2025 -2,591.38
Dec 19, 2025 -2,542.02
Dec 18, 2025 -2,492.66
Dec 17, 2025 -2,402.17
Dec 16, 2025 -2,525.56
Dec 15, 2025 -2,476.20
Dec 12, 2025 -2,706.55
Dec 11, 2025 -2,813.49
Dec 10, 2025 -2,755.91
Dec 9, 2025 -2,764.14
Dec 8, 2025 -2,706.55
Dec 5, 2025 -2,813.49
Dec 4, 2025 -2,821.72
Dec 3, 2025 -2,862.85
Dec 2, 2025 -2,747.68